U.S. Markets open in 3 hrs 45 mins

Lawsuit against Columbia Laboratories and Actavis dismissed

Columbia Laboratories (CBRX) announced that the previously disclosed Consolidated Second Amended Class Action Complaint to the putative class action lawsuit filed against the company, Actavis (ACT), and certain officers of both companies in the U.S. District Court, District of New Jersey, entitled In re Columbia Laboratories, Inc., Securities Litigation, has been dismissed. The court ruled that changes the plaintiffs made to their first amended complaint “still do not create a strong inference that (Columbia) acted with an intent to deceive, manipulate or defraud.”